CYTOKINETICS INC — Director's Dealing 2012

Jan 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2012-01-03

Reporting Person: DOW STEPHEN M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-03	Stock Option (Right To Buy)	$.98	A	51020	Acquired	2022-01-03	Common Stock (51020)	Direct

Footnotes

F1: Options vest and become exerciseable in equal monthly installments and shall be 100% vested on January 3, 2013.

F2: This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of an annual cash retainer of $20,000.